(Q48525508)

12 February 2018

title

Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis. (English)

1 reference

12 February 2018

1 reference

L Dorado

1

1 reference

12 February 2018

M Millán

2

1 reference

12 February 2018

N Pérez de la Ossa

3

1 reference

12 February 2018

C Guerrero

4

1 reference

12 February 2018

M Gomis

5

1 reference

12 February 2018

A Aleu

6

1 reference

12 February 2018

E López-Cancio

7

1 reference

12 February 2018

P Cuadras

8

1 reference

12 February 2018

A Dávalos

9

1 reference

12 February 2018

publication date

8 May 2012

1 reference

12 February 2018

European Journal of Neurology

published in

1 reference

12 February 2018

volume

19

1 reference

12 February 2018

issue

9

1 reference

12 February 2018

page(s)

1251-1255

1 reference

12 February 2018

Tissue plasminogen activator for acute ischemic stroke

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Recanalization after intravenous thrombolysis: does a recanalization time window exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03743.X

10.1111/J.1468-1331.2012.03743.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

22568604

1 reference

12 February 2018